Physician

Saralyn Notaro-Rietz, MD

According to 2025 Medicare claims, Saralyn Notaro-Rietz, MD (NPI: 1013981836) practices ophthalmology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. Notaro-Rietz uses personal NPI as billing NPI and primary practice location at 14226-4467.

Notaro-Rietz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 248 traditional Medicare patients, billed 4,901 HCPCS/CPT codes, and received $302,305 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 233 prescription claims across 64 beneficiaries totaling $147,057 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 6 records totaling $193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $26,318 to $147,057. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$151K$302K2015 Medicare payment: $293,721 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $231,081 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $203,005 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $158,053 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $154,801 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $151,914 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $116,105 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $131,797 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $167,450 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $302,305 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153402,934$293,721
20163513,131$231,081
20173603,367$203,005
20183392,638$158,053
20193442,826$154,801
20202731,997$151,914
20212742,098$116,105
20222622,000$131,797
20232532,398$167,450
20242484,901$302,305

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$74K$147K2015 Drug cost: $26,318 (USD; Tot_Drug_Cst)2016 Drug cost: $31,799 (USD; Tot_Drug_Cst)2017 Drug cost: $35,756 (USD; Tot_Drug_Cst)2018 Drug cost: $72,052 (USD; Tot_Drug_Cst)2019 Drug cost: $87,825 (USD; Tot_Drug_Cst)2020 Drug cost: $109,044 (USD; Tot_Drug_Cst)2021 Drug cost: $73,254 (USD; Tot_Drug_Cst)2022 Drug cost: $71,388 (USD; Tot_Drug_Cst)2023 Drug cost: $100,897 (USD; Tot_Drug_Cst)2024 Drug cost: $147,057 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201543158$26,318
201638195$31,799
201747134$35,756
201861205$72,052
201951162$87,825
202059196$109,044
202161171$73,254
202252163$71,388
202352147$100,897
202464233$147,057

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92235Exam of retinal blood vessels using a special camera after injection of a dye4350$124
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8194$95
67028Injection of drug into eye57298$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more179281$61
92134Imaging of retina185610$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept471,316$106,712
VabysmoFaricimab-Svoa11308$31,262
Prednisolone AcetatePrednisolone Acetate714,218$4,664
Ketorolac TromethamineKetorolac Tromethamine462,164$1,148
Atropine SulfateAtropine Sulfate13907$844

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$193Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Saralyn Notaro-Rietz, MD?

Tedicare shows public-source Medicare data for Saralyn Notaro-Rietz, MD (NPI 1013981836), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Saralyn Notaro-Rietz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Saralyn Notaro-Rietz, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Saralyn Notaro-Rietz, MD have Open Payments data?

Saralyn Notaro-Rietz, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.